Longevity & AgingResearch PaperPaywall

Wearable gait sensors confirm what a simple leg function questionnaire reveals in chronic wound patients

In 104 patients with chronic leg wounds, lower self-reported function scores matched slower, less stable gait on wearable sensors in a cross-sectional study.

Thursday, November 19, 2026 0 views
Published in J Plast Reconstr Aesthet Surg
Patient walking down a clinic hallway with small wearable gait sensors on the ankles while a clinician watches a tablet.

Summary

Keeping people walking is central to limb salvage in chronic lower extremity wound care. This single-center study asked whether a short patient questionnaire, the Lower Extremity Function Scale (LEFS), tracks with objective gait measured by wearable sensors. In 104 patients without open wounds who could walk unassisted, 23.1% had mild-minimal function (LEFS <41) and 76.9% had moderate-high function. The higher-function group walked faster, took longer strides, had faster cadence, spent more time on a single limb and swayed less (all p<0.001). Comorbidities did not differ between groups. This is a correlation of a surrogate with a surrogate. The abstract reports no outcomes such as amputation, falls or wound recurrence, so whether either measure identifies patients at risk of adverse outcomes remains untested.

Detailed Summary

Why it matters: Walking ability is a core goal of limb salvage, and mobility is also a strong marker of healthy aging. Clinicians can ask patients about function or measure it objectively with wearable sensors, but it is unclear how well the two agree.

What was studied: Between June 2021 and February 2024, adults aged 18 or older with a history of chronic lower extremity wounds, but no open wounds at testing and able to walk safely without assistance or pain, completed the LEFS questionnaire, a walk test and a Romberg sway test, all with wearable sensors. Patients were grouped as moderate-high function (LEFS ≥41) or mild-minimal function (LEFS <41).

Key results: Of 104 patients, 76.9% were moderate-high and 23.1% mild-minimal. The moderate-high group had faster gait speed, shorter step duration, faster cadence, longer strides, more single limb support and better stability (all p<0.001). Comorbidities did not differ significantly. In multivariate analysis, high function independently predicted better gait on most parameters.

Implications: The authors suggest the LEFS could be used in clinical practice as a quick proxy for gait impairment, and they describe this as the first study to link sensor-based gait data with PROMs in this population.

Caveats: The design appears cross-sectional, so it shows correlation, not prediction. The stated aim was to identify patients at risk of adverse outcomes, but the abstract reports no outcome data. Only walking patients without open wounds were included, so findings may not extend to more impaired patients. Only the abstract was available for this summary.

Key Findings

  • 104 patients tested; 76.9% had moderate-high function (LEFS ≥41) and 23.1% mild-minimal function.
  • Higher-function patients had faster gait speed, cadence and longer strides than the lower-function group (all p<0.001).
  • Single limb support and sway stability were also better in the moderate-high group (p<0.001).
  • Comorbidities did not differ significantly between groups; high function independently predicted better gait on most parameters.
  • No adverse clinical outcomes (amputation, falls, wound recurrence) are reported in the abstract.

Methodology

Single-center study at MedStar Georgetown, enrolling adults from June 2021 to February 2024 who had no open wounds and could walk unassisted without pain. Participants completed the LEFS, a walk test and a Romberg sway test with wearable sensors, and were split at LEFS 41 for comparison, with multivariate adjustment. The abstract does not specify the statistical model details or follow-up.

Study Limitations

The design appears cross-sectional, with a modest sample, a single center, and an arbitrary LEFS cutoff. The abstract reports no hard outcomes, so the stated aim of identifying patients at risk of adverse events is not demonstrated. Only patients who could walk safely without assistance were included, limiting generalizability, and this summary rests on the abstract alone.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: